Novimmune (global rights to emapalumab) is Buildings and Property in Switzerland that focus on developer business. They cover business area such as developer, manufacturer, antibody-base drug, inflammatory disease, immune-relate disorder, cancer.
-
Developer
-
14 Chemin des Aulx
1228 Plan-Les-Ouates
Geneva
Switzerland
Private
developermanufacturerantibody-base druginflammatory diseaseimmune-relate disordercancer
* We use standard office opening hours in near Novimmune (global rights to emapalumab)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Novimmune (global Rights To Emapalumab) is Buildings and Property business from Switzerland that founded in - ( years old in ), Novimmune (global rights to emapalumab) business is focusing on Developer.
Novimmune (global rights to emapalumab) headquarter office and corporate office address is located in 14 Chemin des Aulx 1228 Plan-Les-Ouates Geneva Switzerland.
Novimmune (global rights to emapalumab) was founded in Switzerland.
In , Novimmune (global rights to emapalumab) is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Novimmune (global rights to emapalumab), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
